Glackin C - Search Results

1

TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells.

Eide T, Ramberg H, Glackin C, Tindall D, Taskén KA. Eide T, et al. Among authors: glackin c. Cancer Cell Int. 2013 Jan 31;13(1):4. doi: 10.1186/1475-2867-13-4. Cancer Cell Int. 2013. PMID: 23368843 Free PMC article.

2

N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1.

Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, Heimark RL. Alexander NR, et al. Among authors: glackin c. Cancer Res. 2006 Apr 1;66(7):3365-9. doi: 10.1158/0008-5472.CAN-05-3401. Cancer Res. 2006. PMID: 16585154

3

Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.

Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, Wong YC, Wang X. Kwok WK, et al. Among authors: glackin c. Cancer Res. 2005 Jun 15;65(12):5153-62. doi: 10.1158/0008-5472.CAN-04-3785. Cancer Res. 2005. PMID: 15958559 Free article.

4

Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target.

Roberts CM, Shahin SA, Loeza J, Dellinger TH, Williams JC, Glackin CA. Roberts CM, et al. Among authors: glackin ca. BMC Cancer. 2017 Mar 10;17(1):184. doi: 10.1186/s12885-017-3169-9. BMC Cancer. 2017. PMID: 28283022 Free PMC article.

5

TWIST1 promotes invasion through mesenchymal change in human glioblastoma.

Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H, González-Herrero I, Sánchez-García I, Silber JR, Horner PJ, Rostomily RC. Mikheeva SA, et al. Among authors: glackin ca. Mol Cancer. 2010 Jul 20;9:194. doi: 10.1186/1476-4598-9-194. Mol Cancer. 2010. PMID: 20646316 Free PMC article.

6

Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Mironchik Y, Winnard PT Jr, Vesuna F, Kato Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, Burger H, Glackin C, Raman V. Mironchik Y, et al. Among authors: glackin c. Cancer Res. 2005 Dec 1;65(23):10801-9. doi: 10.1158/0008-5472.CAN-05-0712. Cancer Res. 2005. PMID: 16322226 Free PMC article.

7

Twist overexpression promotes chromosomal instability in the breast cancer cell line MCF-7.

Vesuna F, Winnard P Jr, Glackin C, Raman V. Vesuna F, et al. Among authors: glackin c. Cancer Genet Cytogenet. 2006 Jun;167(2):189-91. doi: 10.1016/j.cancergencyto.2006.01.014. Cancer Genet Cytogenet. 2006. PMID: 16737925 Free PMC article. No abstract available.

8

RNA-based TWIST1 inhibition via dendrimer complex to reduce breast cancer cell metastasis.

Finlay J, Roberts CM, Lowe G, Loeza J, Rossi JJ, Glackin CA. Finlay J, et al. Biomed Res Int. 2015;2015:382745. doi: 10.1155/2015/382745. Epub 2015 Feb 11. Biomed Res Int. 2015. PMID: 25759817 Free PMC article.

9

TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling.

Roberts CM, Tran MA, Pitruzzello MC, Wen W, Loeza J, Dellinger TH, Mor G, Glackin CA. Roberts CM, et al. Among authors: glackin ca. Sci Rep. 2016 Nov 23;6:37652. doi: 10.1038/srep37652. Sci Rep. 2016. PMID: 27876874 Free PMC article.

10

Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.

Finlay J, Roberts CM, Dong J, Zink JI, Tamanoi F, Glackin CA. Finlay J, et al. Nanomedicine. 2015 Oct;11(7):1657-66. doi: 10.1016/j.nano.2015.05.011. Epub 2015 Jun 24. Nanomedicine. 2015. PMID: 26115637 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page